| 20.35 Delayed Data As of Jul 19 |  -0.54 / -2.58%Today’s Change | 18.14 Today|||52-Week Range 21.20 | +8.53% Year-to-Date |
| Previous close | 20.89 |
| Today’s open | 20.42 |
| Day’s range | 20.30 - 20.42 |
| Volume | 780 |
| Average volume (3 months) | 2,405 |
| Market cap | $101.4B |
| Earnings growth (last year) | +143.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.72% |
| P/E ratio | 14.7 |
| Price/Sales | 2.30 |
| Price/Book | 18.02 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $41.1B |
| Annual profit (last year) | $4.8B |
| Net profit margin | 11.75% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Emma Walmsley |
Chief Financial Officer & Executive Director Iain James Mackay |
Corporate headquarters Brentford, Greater London |
